The World Veterinary Vaccine Congress 2017 is dedicated to pharma, biotech, government – scientific departments and regulators, academia, venture capital, payers / reimbursers.
The World Veterinary Vaccine Congress 2017 covers topics such as:
- DEVELOPING AND FORMULATING NEW VACCINES: From novel combination adjuvants for veterinary vaccines to making vaccines more affordable, meet experts who can delve into process improvements approaches when developing new vaccines
- NEW VACCINE TECHNOLOGY AND PLATFORMS: From modified live virus vaccines, DNA vaccines, subunit marker vaccines to novel adjuvanted vaccines, this congress brings all innovation together in one place
- FROM AGENT IDENTIFICATION TO VACCINE SUPPLY: Find out how to tackle the problems associated with identification of new threats and the turnaround time to producing vaccines. Discuss how the industry can readjust the risk assessment when responding to a new outbreak
- ANTIMICROBIAL RESISTANCE AND EMERGING DISEASES: Expect the unexpected, explore the opportunities and challenges associated with emerging infectious diseases including African swine fever, avian influenza and Rift Valley Fever
The World Veterinary Vaccine Congress 2017 brings together senior attendees with job titles such as:
- Chief Scientific Officer
- Chief Executive Officer
- Chief Medical Officer
- Chief Business Officer
- Clinical Research
- Research and Development
- Scientific Affairs
- Clinical Development
- Regulatory Affairs
- Medical Affairs
- Manufacturing
- Commercial Operations
- Strategic Development
- Corporate Development
- Business Development
